MedTrace Logo

Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma

NCT01383525 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2020-02-26

No results posted yet for this study

Summary

The trial objectives are to establish the safety \& efficacy of using a DLTP laser to perform laser trabeculoplasty to reduce Intraocular Pressure (IOP) in patients with open angle glaucoma (Including Pigmentary \& Exfoliative Glaucoma), that did not achieve adequate IOP control by conventional therapy.

Conditions

Interventions

DEVICE

Direct Selective Trabeculoplasty device

Patients will be treated with a Direct Selective Trabeculoplasty (DLTP) laser. Placement of the spots is on the sclera around the limbus.

Sponsors & Collaborators

  • Horizon 2020 - European Commission

    collaborator OTHER

  • BelkinVision

    lead INDUSTRY

Principal Investigators

  • Alon Skaat, MD · Sheba Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2019-08-31
Completion
2019-11-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01383525 on ClinicalTrials.gov